Claudio Bordignon
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice.
CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice.
Journal: Frontiers in immunology
Published: September 11, 2019
The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer.
Journal: Journal for immunotherapy of cancer
Published: September 28, 2018
Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma.
Journal: Frontiers in immunology
Published: September 21, 2018
Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene.
Journal: Frontiers in immunology
Published: November 09, 2017
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells.
Journal: Nature medicine
Published: July 30, 2017
Twenty-five years of gene therapy for genetic diseases and leukemia: The road to marketing authorization of the first ex vivo gene therapies.
Journal: Journal of autoimmunity
Published: July 05, 2017
Codon Optimization Leads to Functional Impairment of RD114-TR Envelope Glycoprotein.
Journal: Molecular therapy. Methods & clinical development
Published: November 29, 2016
24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 28, 2016
Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes.
Journal: Molecular therapy. Methods & clinical development
Published: June 23, 2016
The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice.
Journal: Cancer immunology, immunotherapy : CII
Published: March 04, 2016
Last Updated: 09/26/2026